Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 104 results for "cadila healthcare"

Cadila Healthcare Board approves Sub-division of equity shares
India Infoline

Cadila Healthcare to hold board meeting

RECOMMENDED FOR YOU Business Standard, 13 hours ago
Cadila Healthcare awaits nod for fund infusion Business Line, 1 month ago

35 images for cadila healthcare

Business Standard, 1 day ago
Business Standard, 1 week ago
India Infoline, 2 weeks ago
MSN News US, 4 days ago
India Infoline, 1 week ago
PR inside, 1 week ago
PR inside, 1 month ago
India Infoline, 1 week ago
India Infoline, 1 week ago
Money Control, 1 month ago
Business Standard

Cadila Healthcare turns ex-stock split

Thus far in 2015, the stock has outperformed the market by gaining 30% against 3% decline in the S&P BSE Sensex. SI Reporter | Mumbai October 6, 2015 Last Updated at 10:01 IST Cadila Healthcare were trading higher by 2% at Rs 424 on the BSE after the stock ...
 Business Standard1 day ago Cadila Healthcare to turn ex-split today  Business Line2 days ago Cadila Healthcare gains over 1% after its inclusion in the NSE derivatives market  India Infoline1 week ago Cadila Healthcare gains after fixing record date for stock split  Business Standard2 weeks ago

Cadila Healthcare's Q2 results on Oct 22, 2015

Cadila Healthcare Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on October 22, 2015, inter alia, to consider approve the unaudited financial results for the quarter and half year ended on September 30, 2015 (Q2).
 Money Control1 day ago Cadila Healthcare: Outperformance continues in Q1  Business Standard1 month ago Cadila Healthcare shares surge over 5% as Q1 net jumps  Business Standard1 month ago Cadila Healthcare posts 47% rise in Q1 profit  Livemint.com1 month ago
Business Standard

Cadila Healthcare, Marico advance up to 4% on F&O inclusion

A bout of buying was also observed on Marico, which rose 2.68 per cent to hit a high of Rs 406. Bharti Infratel, which has also been included in the F segment, jumped as much as 3 per cent in morning trade. But the scrip erased entire gains and was trading in ...
 Economic Times1 week ago Select stocks gain on F&O inclusion; Cadila Healthcare hits record high  Business Standard1 week ago Shares Included In F&O Segment Rally  One India1 week ago BEML, Cadila, Marico, NCC rally on addition in FO segment  Money Control1 week ago

Pharma shares in focus; Lupin hits lifetime high

Lupin, Sun Pharma, Dr Reddy's Lab, Cadila Healthcare, Aurobindo Pharma were up 1%-4% on the NSE. SI Reporter | Mumbai October 1, 2015 Last Updated at 15:06 IST Shares of pharmaceuticals companies are trading higher in otherwise subdued market with CNX Pharma ...
 Business Standard6 days ago Several pharma shares scale new 52-week highs in a flattish broad market  First Post.com2 months ago Cadila Healthcare remains preferred pick in pharma space: Hemang Jani, Sr VP, Sharekhan  Economic Times2 months ago
India Infoline

Aarti Inds, Cadila Healthcare, 25 other scrips hit all-time high

*Password should have 8 to 12 Alphanumeric Characters with one Special Character. Confirm Password I want to create a User ID and have read the terms and conditions for the same Register Now Connect with We encourage visitors to register on IIFL. Registering ...
 India Infoline1 week ago Aarti Ind, Cadila Healthcare and Neuland Lab hit all time high  India Infoline1 week ago
Digital Journal

Male Infertility Market Size, Segmentation To 2022: Grand View Research, Inc.

Global is expected to exhibit a steady growth during the forecast period owing to growing awareness of people about such disorders and becoming more concerned about own health overcoming the social stigma and guilt. According to the WHO, 1 in every ...
 Digital Journal5 hours ago

Canadian antibody R&D organisation eyes India

The Centre for Commercialisation of Antibodies and Biologics (CCAB), a Canadian Federally-funded Centre of Excellence for Commercialisation and Research, organised its second business meet in Bengaluru on Tuesday along with the Canada India Business Exchange, ...
 Deccan Herald1 day ago

Baxalta and Momenta Pharma commence pivotal trial of HUMIRA biosimilar; regulatory filing targeted for 2017

Baxalta (NYSE:BXLT) and collaboration partner Momenta Pharmaceuticals (NASDAQ:MNTA) announce the initiation of a pivotal clinical trial comparing the safety, efficacy and immunogenicity of their biosimilar candidate, M923 , to AbbVie's (NYSE:ABBV) ...
 TeleTrader.com2 days ago
APN News

Organisations with HR excellence acknowledged at SHRM India Annual Conference 2015

Previous story: HSIL introduces New Range of Instant Water Heaters Next story: Kewtown makeover receives Best Community Residential unit in South Africa award New Delhi: After the tremendous success of HR awards in the previous years, SHRM ...
 APN News2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cadila healthcare
Get updated on latest news & your favorite topics right in your inbox!
More     Less